Mapping the Health Status of the Population of French Polynesia: the MATAEA Project

NCT06133400 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1942

Last updated 2023-11-18

No results posted yet for this study

Summary

This is a cross-sectional study carried out on a sample of the adult population aged 18 to 69, distributed over the five archipelagos of French Polynesia.

Participation in the study involves: agreement to answer a questionnaire to collect information on socio-demographic characteristics, lifestyle habits and medical history; physical measurements (height, weight, waist circumference, blood pressure and skin pigmentation); and agreement to take biological samples (blood, saliva and stool) for biological, genetic and microbiological analyses.

The aim of the study is to assess the current health status of the population of French Polynesia and to evaluate the influence of contextual risk factors (lifestyle, place of residence, history of infection) and intrinsic susceptibility factors (genetics, age, gender, microbiota) in relation to non-communicable and infectious diseases.

Conditions

  • Non Communicable Diseases
  • Microbiome
  • Communicable Diseases
  • Pesticide Exposure
  • Metal Poison
  • Genetics Population
  • Ciguatera

Interventions

OTHER

Questionnaire

Questionnaire about socio-demographical status, health status and lifestyle habits

OTHER

Physical measurements

Measurement of height, weight, waist circumference, blood pressure and skin pigmentation

OTHER

Biological samples

Collect venous blood, saliva and stool samples

Sponsors & Collaborators

  • Institut Pasteur

    collaborator INDUSTRY
  • Institut de la Statistique de la Polynésie française

    collaborator UNKNOWN
  • Centre Hospitalier de la Polynésie française

    collaborator UNKNOWN
  • Université de la Polynésie française

    collaborator UNKNOWN
  • Institut National en Santé Publique du Québec

    collaborator OTHER
  • Institut Louis Malardé

    lead OTHER

Principal Investigators

  • Van-Mai CAO-LORMEAU, PhD · Institut Louis Malardé

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-04
Primary Completion
2021-12-08
Completion
2021-12-08

Countries

  • French Polynesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06133400 on ClinicalTrials.gov